Author

Furkan Guvenc

University of TorontoORCID 0000-0002-6978-8217Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Natasha Christie-HolmesiD· 2 shared Patrick Budylowski· 2 shared Samira MubarekaiD· 2 shared Scott D. Gray‐OweniD· 2 shared Adrian Granda FariasiD· 1 shared Amy H.Y. TongiD· 1 shared Amy NouanesengsyiD· 1 shared Andrea Habsid· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Natasha Christie-HolmesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologybioRxivPreprintJun 28, 2021

Systematic genome-scale identification of host factors for SARS-CoV-2 infection across models yields a core single gene dependency; ACE2

Katherine Chan, Adrian Granda Farias, Hunsang Lee…·Jason Moffat

The paper identifies ACE2 as the only common host dependency for SARS-CoV-2 across multiple cell lines, while other host factors are cell line specific.

1 citation

humanCRISPR screen

𝕏 PostBluesky

Molecular BiologyNature CommunicationsPeer-reviewedJun 16, 2021

Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers

Edurne Rujas, Iga Kucharska, Yong Zi Tan…·Jean‐Philippe Julien

The paper describes a multimerization platform that transforms antibodies into potent, broad-spectrum neutralizers against SARS-CoV-2.

78 citationstop 4%

experimental assaydrug response / drug discovery

𝕏 PostBluesky